Industry News

Ironshore Pharmaceuticals Announces JORNAY PM™ (METHYLPHENIDATE HCL) CII, the first and only ADHD stimulant dosed in the evenings

Government of Canada approves new treatment options for opioid use disorder and supports research, treatment and harm reduction projects in Ontario

AVROBIO, Inc. Announces FDA Clearance of Investigational New Drug Application for AVR-RD-01 Gene Therapy for the Treatment of Fabry Disease

AVROBIO, Inc. Announces Updated Clinical Data from Ongoing Phase 1 and Phase 2 Studies for AVR-RD-01 Gene Therapy for Fabry Disease

Milestone Pharmaceuticals Announces First Patient Randomized in the Phase 3 NODE-301 Clinical Trial Evaluating Etripamil for Termination of Paroxysmal Supraventricular Tachycardia (PSVT) Episodes

Sentien Co-Founder Dr. Biju Parekkadan Gives a Live Interview at World Advanced Therapies & Regenerative Medicine Congress

Neuroquest and Concept 2 Clinic Inc. Announces Results Of Extensive Market Research

© Copyright - Concept 2 Clinic

Become A Concept2Clinic Partner

Join one of the worlds strongest biotech forces

Fill out the information below and one of our qualified representatives will get back to you shortly.